InsidersTradesSigma
신신제약: directors' dealings · South Korea · DART (FSS)
DART:company-74a08bKR·DART (FSS)Mcap 81.5Bn€Healthcare
Explore the full management transaction log of 신신제약, a listed issuer based in South Korea. Shares are quoted on KR KR, under the oversight of DART (FSS). Operating in the Healthcare sector, 신신제약 has published 1 insider filings. Market capitalisation: €81.5bn. The latest transaction was filed on 11 March 2026 — Other. Among the most active insiders: 신신제약. The full history is free.
1
Insider Decl.
0
Thresholds
·
0 ops.
Buy Volume
·
0 ops.
Sell Volume
Financial data
FY ended December 2025 · cache
5370.00 €
Analyst consensus
Income statement
Revenue113.78 Bn€
Gross profit43.11 Bn€38% margin
Net income9.29 Bn€8.2% margin
Valuation
Beta0.27
Balance sheet & cash
Market cap81.47 Bn€
Total debt43.69 Bn€
Free Cash Flow6.97 Bn€
Debt / Equity59%
Profitability & ownership
ROE13.3%
ROA5.1%
% insiders52.0%
% institutions0.0%
Last declaration on 11 March 2026
Declarations1 total
Executives●Other0DART
DART:20260311003906·details not loaded
1 of 1 declaration